Compound Detail
CHEMBL2071260
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)n(CCNc2ccnc3cc(Cl)ccc23)c1=O
Basic Information
| ChEMBL ID | CHEMBL2071260 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XCBMFEORUZCDML-IPMKNSEASA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
471.9
MW (Da)
2.59
ALogP
9
HBA
2
HBD
147.1
PSA (Ų)
0.31
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.34
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 6.34 | 6.265 | 460.0 | 2 |
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 5.15 | 5.15 | 7150.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Plasmodium falciparum | IC50 | = | 460.0 | nM | 6.34 | Antiplasmodial activity against Plasmodium falciparum 3D7 ring stage cells asses... | 22858300 |
| Plasmodium falciparum | IC50 | = | 650.0 | nM | 6.19 | Antiplasmodial activity against drug resistant Plasmodium falciparum Dd2 ring st... | 22858300 |
| Human immunodeficiency virus 1 | IC50 | = | 7150.0 | nM | 5.15 | Antiviral activity against VSV-G pseudotyped HIV1 lentiviral particles infected ... | 22858300 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22858300 | 10.1016/j.bmc.2012.06.038 | Unchecked | 3 |
| 22858300 | 10.1016/j.bmc.2012.06.038 | Plasmodium falciparum | 2 |
| 22858300 | 10.1016/j.bmc.2012.06.038 | Human immunodeficiency virus 1 | 1 |
| 22858300 | 10.1016/j.bmc.2012.06.038 | HeLa | 1 |
Data from ChEMBL 36 via Core Engine